Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Viney, Nicholas J, van Capelleveen, Julian C, Geary, Richard S · The Lancet · 2016